Enzo Biochem, Inc. Share Price

Equities

ENZ

US2941001024

Biotechnology & Medical Research

Delayed Nyse 14:33:13 29/04/2024 BST 5-day change 1st Jan Change
1.05 USD 0.00% Intraday chart for Enzo Biochem, Inc. -3.67% -24.46%
Sales 2022 107M 8.55B Sales 2023 31.06M 2.48B Capitalization 73.6M 5.88B
Net income 2022 -18M -1.44B Net income 2023 20M 1.6B EV / Sales 2022 1.07 x
Net cash position 2022 1.02M 81.13M Net cash position 2023 75.38M 6.02B EV / Sales 2023 -0.06 x
P/E ratio 2022
-6.24 x
P/E ratio 2023
3.59 x
Employees 185
Yield 2022 *
-
Yield 2023
-
Free-Float 75.81%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.48%
1 week-3.67%
Current month-17.32%
1 month-16.00%
3 months-17.32%
6 months-25.53%
Current year-24.46%
More quotes
1 week
1.04
Extreme 1.04
1.11
1 month
1.04
Extreme 1.04
1.30
Current year
1.04
Extreme 1.04
1.50
1 year
1.04
Extreme 1.04
2.74
3 years
1.00
Extreme 1
4.15
5 years
1.00
Extreme 1
4.85
10 years
1.00
Extreme 1
12.04
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 31/12/10
Founder 81 31/07/76
Director of Finance/CFO 47 -
Members of the board TitleAgeSince
Chairman 64 25/10/23
Director/Board Member 58 16/11/20
Director/Board Member 50 02/01/22
More insiders
Date Price Change Volume
29/04/24 1.05 0.00% 2 312
26/04/24 1.05 -1.87% 114,913
25/04/24 1.07 +0.94% 74,257
24/04/24 1.06 -2.75% 77,230
23/04/24 1.09 0.00% 76,123

Delayed Quote Nyse, April 29, 2024 at 02:33 pm

More quotes
Enzo Biochem, Inc. is focused on molecular diagnostics and has a portfolio of technical platforms and reagent sets supporting a diverse range of biomedical research and translational science needs. The Company operates through the product segment, which manufactures, develops and markets products and tools for clinical research, translational research, drug development and bioscience research customers worldwide. The Company is engaged in product development and manufactures and supplies a comprehensive portfolio of products, including antibodies, genomic probes, assays, biochemicals and proteins. The Company's products and technologies are used in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry and small molecule chemistry. Its life science division supports the work of research centers and industry partners. It has built a portfolio of intellectual property assets, comprised of around 457 owned patents worldwide.
More about the company